IJPRS

Home Abstract

Pharmacovigilance Requirements for Biologic Products in India


Received On: 02/08/2017
Accepted On: 22/08/2017


Author(s)

Reddy, P.M., Venkatesh, M.P., Balamuralidhara, V., Abhishek, B.V.


Author's Affiliation


Abstract

The term Pharmacovigilance mean all scientific and data gathering activities related to the detection, assessment, and understanding of adverse events. It principally involves the identification and evaluation of safety signals. It also requires detection of any change in benefit-risk balance during its entire life cycle. With the increasing complexity of medications available today, a comprehensive ADR monitoring system is necessary to detect, evaluate, and develop mechanisms to prevent ADRs. Risk assessment during product development should be conducted thoroughly and rigorously; however, it is impossible to identify all safety concerns during clinical trials. Therefore, postmarketing surveillance which may be passive or stimulating has a significant role in assessing the actual safety aspects of the vaccine product.


Keywords

ADR, Safety signal, Post-marketing surveillance

Cite This Article

Reddy, P.M., Venkatesh, M.P., Balamuralidhara, V., Abhishek, B.V. (2017). Pharmacovigilance Requirements for Biologic Products in India. International Journal for Pharmaceutical Research Scholars (IJPRS), 6(3), 44-49.


Recent Articles

Get FREE Updates for Upcoming
Pharma News, Jobs & Conferences

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

IJPRS will use the information you provide on this form to be in touch with you and to provide updates and marketing.